Cardiovascular damage in seronegative spondylarthritis
pdf

Keywords

seronegative spondyloarthritis
cardiovascular system
ECG

How to Cite

STOICA, M., SCORPAN, A., SARBU, O., GOREA, A. and ISTRATI, V. (2022) “Cardiovascular damage in seronegative spondylarthritis”, One Health & Risk Management , 3(2). Available at: https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/303 (Accessed: 19June2025).

Abstract

Introduction. Cardiovascular mortality in patients diagnosed with seronegative spondyloarthritis (SSN) is on the rise. Impairment of the cardiovascular system in ankylosing spondylitis (SpA) is 20-40%, in psoriatic arthritis (APs) 18-22% and in reactive arthritis (ARe) 1-3%.
Material and methods. The study included 77 patients diagnosed with SSN. Laboratory (erythrocyte sedimentation rate – ESR, C-reactive protein – CRP, fibrinogen) and instrumental (echocardiography – EcoCG, electrocardiogram – ECG) data were analyzed.
Results. In 35 patients diagnosed with SpA, the left branch hemiblock of the Hiss bundle was determined – 71% and bradycardia – 57%. Aortic valve (VAo) changes were diagnosed in 54% and left ventricular hypertrophy (LVH) in 57%. Elevated CRP values were found in 34.5% of cases, ESR – 22.8% and fibrinogen – 17.2%. In 24 patients with APs, 33.5% showed VAo induration and fibrosis. Another change diagnosed in these patients was LVH (37.5%). Cardiac conductivity disorders in 25% were due to the left branch hemiblock of the Hiss bundle, and among the increased inflammatory markers were: fibrinogen (16.6%) and CRP (12.5%). In 18 patients with ARe as a rhythm disorder, tachycardia is predominant – 94% and VAo damage in 27.7%. Inflammatory markers with values above the upper limit were fibrinogen (66%) and CRP (33%).
Conclusions. Our study showed that SSN is closely related to the inflammatory syn-drome, on which the activity of the disease and the degree of damage to the cardiovascular system depend. Most often the heart is affected with its components.

pdf

|Views: 306| |pdf Downloads: 186|


pdf
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Downloads

Download data is not yet available.

ANNOUNCEMENT

Starting from July 1, 2025, the article processing fee will be 20 EUR (or the equivalent in MDL at the official exchange rate of the National Bank of Moldova). The publication fee for an accepted article will be 150 EUR (or the equivalent in MDL).

Details here:

Processing Fee
A processing fee of 20 EUR (or the equivalent in MDL) will be charged for articles accepted for scientific review by the editorial committee of the One Health and Risk Management journal.
Note: This fee will only be charged if your article has been technically reviewed and accepted.

Publication Fee
Starting from 01.07.2025, a fee of 150 EUR (or the equivalent in MDL) will be charged for articles accepted for publication.
Additionally, authors will bear the cost of English language editing/translation services if the manuscript requires intervention. The fee is 5 EUR (or the equivalent in MDL) per page edited/translated.
The total cost for English editing/translation services will be communicated by the Editorial Board after the manuscript is accepted for publication.

Payment Details:
Payments should be made in MDL to the bank account opened in the name of the Biosafety and Biosecurity Association of the Republic of Moldova.
The invoice will be issued by the end of the month in which the payment was made.

Organization: Biosafety and Biosecurity Association of the Republic of Moldova
Address: 5C A. Cozmescu Street
Fiscal Code: 1017620004120
Bank Code (SWIFT): AGRNMD2X451
IBAN: MD34AG000000022513622370